POLYARTICULAR JUVENILE IDIOPATHIC ARTHRITIS
Clinical trials for POLYARTICULAR JUVENILE IDIOPATHIC ARTHRITIS explained in plain language.
Never miss a new study
Get alerted when new POLYARTICULAR JUVENILE IDIOPATHIC ARTHRITIS trials appear
Sign up with your email to follow new studies for POLYARTICULAR JUVENILE IDIOPATHIC ARTHRITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Drug maker tracks Kids' arthritis treatment experience
Disease control Recruiting nowThis study monitors the safety and effectiveness of Xeljanz in children with juvenile arthritis during routine medical care in Korea. It follows 10 patients aged 2-18 who are already prescribed Xeljanz for up to 44 weeks. The goal is to collect real-world information about how ch…
Matched conditions: POLYARTICULAR JUVENILE IDIOPATHIC ARTHRITIS
Sponsor: Pfizer • Aim: Disease control
Last updated Apr 02, 2026 14:57 UTC
-
New hope for kids with untreatable autoimmune diseases
Disease control Recruiting nowThis is an early-stage study testing a new type of cell therapy called BCMA/CD70 CAR-T for children with severe rheumatic diseases that have not responded to standard treatments. The trial aims to see if this therapy is safe and can reduce disease activity in conditions like juve…
Matched conditions: POLYARTICULAR JUVENILE IDIOPATHIC ARTHRITIS
Phase: PHASE1 • Sponsor: Chongqing Precision Biotech Co., Ltd • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC